Ekong E - Search Results

1

Impact of HIV type 1 subtype on drug resistance mutations in Nigerian patients failing first-line therapy.

Chaplin B, Eisen G, Idoko J, Onwujekwe D, Idigbe E, Adewole I, Gashau W, Meloni S, Sarr AD, Sankalé JL, Ekong E, Murphy RL, Kanki P. Chaplin B, et al. Among authors: ekong e. AIDS Res Hum Retroviruses. 2011 Jan;27(1):71-80. doi: 10.1089/aid.2010.0050. Epub 2010 Oct 21. AIDS Res Hum Retroviruses. 2011. PMID: 20964479 Free PMC article.

2

Interplay of reverse transcriptase inhibitor therapy and gag p6 diversity in HIV type 1 subtype G and CRF02_AG.

Ojesina AI, Chaplin B, Sankalé JL, Murphy R, Idigbe E, Adewole I, Ekong E, Idoko J, Kanki PJ. Ojesina AI, et al. Among authors: ekong e. AIDS Res Hum Retroviruses. 2008 Sep;24(9):1167-74. doi: 10.1089/aid.2007.0308. AIDS Res Hum Retroviruses. 2008. PMID: 18729771 Free PMC article.

3

Clinical and genotypic findings in HIV-infected patients with the K65R mutation failing first-line antiretroviral therapy in Nigeria.

Hawkins CA, Chaplin B, Idoko J, Ekong E, Adewole I, Gashau W, Murphy RL, Kanki P; APIN Plus/Harvard PEPFAR Team. Hawkins CA, et al. Among authors: ekong e. J Acquir Immune Defic Syndr. 2009 Oct 1;52(2):228-34. doi: 10.1097/QAI.0b013e3181b06125. J Acquir Immune Defic Syndr. 2009. PMID: 19644383 Free PMC article.

4

Immunologic criteria are poor predictors of virologic outcome: implications for HIV treatment monitoring in resource-limited settings.

Rawizza HE, Chaplin B, Meloni ST, Eisen G, Rao T, Sankalé JL, Dieng-Sarr A, Agbaji O, Onwujekwe DI, Gashau W, Nkado R, Ekong E, Okonkwo P, Murphy RL, Kanki PJ; APIN PEPFAR Team. Rawizza HE, et al. Among authors: ekong e. Clin Infect Dis. 2011 Dec;53(12):1283-90. doi: 10.1093/cid/cir729. Clin Infect Dis. 2011. PMID: 22080121 Free PMC article.

5

Temporal changes in renal glomerular function associated with the use of Tenofovir Disoproxil Fumarate in HIV-infected Nigerians.

Agbaji OO, Agaba PA, Idoko JA, Taiwo B, Murphy R, Kanki P, Ekong E. Agbaji OO, et al. Among authors: ekong e. West Afr J Med. 2011 May-Jun;30(3):164-8. West Afr J Med. 2011. PMID: 22120479

6

Impact of hepatitis B virus infection on human immunodeficiency virus response to antiretroviral therapy in Nigeria.

Idoko J, Meloni S, Muazu M, Nimzing L, Badung B, Hawkins C, Sankalé JL, Ekong E, Murphy R, Kanki P, Thio CL. Idoko J, et al. Among authors: ekong e. Clin Infect Dis. 2009 Oct 15;49(8):1268-73. doi: 10.1086/605675. Clin Infect Dis. 2009. PMID: 19772386 Free PMC article.

7

Impact of hepatitis C virus on HIV response to antiretroviral therapy in Nigeria.

Agbaji O, Thio CL, Meloni S, Graham C, Muazu M, Nimzing L, Idoko J, Sankalé JL, Ekong E, Murphy R, Kanki P, Hawkins C. Agbaji O, et al. Among authors: ekong e. J Acquir Immune Defic Syndr. 2013 Feb 1;62(2):204-7. doi: 10.1097/QAI.0b013e31827ce536. J Acquir Immune Defic Syndr. 2013. PMID: 23196830 Free PMC article.

8

Optimizing treatment switch for virologic failure during first-line antiretroviral therapy in resource-limited settings.

Adetunji AA, Achenbach C, Feinglass J, Darin KM, Scarsi KK, Ekong E, Taiwo BO, Adewole IF, Murphy R. Adetunji AA, et al. Among authors: ekong e. J Int Assoc Provid AIDS Care. 2013 Jul-Aug;12(4):236-40. doi: 10.1177/1545109712463733. Epub 2012 Nov 5. J Int Assoc Provid AIDS Care. 2013. PMID: 23128403 Free PMC article.

9

Epidemiologic and viral predictors of antiretroviral drug resistance among persons living with HIV in a large treatment program in Nigeria.

Ekong E, Ndembi N, Okonkwo P, Dakum P, Idoko J, Banigbe B, Okuma J, Agaba P, Blattner W, Adebamowo C, Charurat M. Ekong E, et al. AIDS Res Ther. 2020 Feb 17;17(1):7. doi: 10.1186/s12981-020-0261-z. AIDS Res Ther. 2020. PMID: 32066473 Free PMC article.

10

Cost-effectiveness of preventing loss to follow-up in HIV treatment programs: a Côte d'Ivoire appraisal.

Losina E, Touré H, Uhler LM, Anglaret X, Paltiel AD, Balestre E, Walensky RP, Messou E, Weinstein MC, Dabis F, Freedberg KA; ART-LINC Collaboration of International Epidemiological Databases to Evaluate AIDS (IeDEA); CEPAC International investigators. Losina E, et al. PLoS Med. 2009 Oct;6(10):e1000173. doi: 10.1371/journal.pmed.1000173. Epub 2009 Oct 27. PLoS Med. 2009. PMID: 19859538 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

50 results

Search Page